Regularly, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. For the December edition, we spoke with Catherine Owen Adams, CEO of Acadia Pharmaceuticals. Tell us about your organization and… read more
On November 14th, EUCOPE together with FTI Consulting EU hosted the event “What Drives Life Sciences Investment in the EU and the Future Impact of the Pharma Package”, to mark the launch of the report, ‘’The Economic Lens: Understanding What Makes the EU Attractive for… read more
ARM, EFPIA, EUCOPE, EuropaBio, Vaccines Europe From 12 January 2025 the Regulation (EU) 2021/2282 on health technology assessment will apply and the first Joint Clinical Assessments (JCA) will be performed to assess the relative clinical effectiveness of new innovative cancer therapies and cell and gene… read more
A new college of Commissioners All signs point towards the need for a more competitive environment for pharmaceutical R&D in Europe. In this context, EUCOPE extends its congratulations to the newly appointed European Commissioners, whose mandates will deliver on large-scale change initiated under the last… read more
Regularly, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. For the November edition, we spoke with Adam Parnaby, Senior Director, Market Access Policy, Europe, Bristol Myers Squibb. Tell us… read more
Brussels, 15 November 2023 Today, EUCOPE and FTI Consulting EU published a report titled The Economic Lens: Understanding What Makes the EU Attractive for Life Sciences Investments. The report provides an analysis of the current environment in the EU for attracting life sciences investments and… read more
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of two new members at its quarterly Members Meeting on 16 October 2024, following Board approval. The new members joining the EUCOPE network are: Avidity Biosciences and Decisive Consulting. EUCOPE’s Secretary General Alexander Natz stated,… read more
On Tuesday 24 September, Alexander Natz, Secretary General of the European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE), sent a letter to the President of the European Commission Ursula von der Leyen, President of the European Parliament Roberta Metsola, and President of the European Council Charles Michel,… read more
On 2 September, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs hosted the eighth episode of its Life Science Lectures webinar series. The focus of the webinar, titled: ‘‘Implementing the European Health Data Space’’ was to delve into the implications of the secondary use of… read more
Every month, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. This September, we spoke with Mike Ryan, Manager, Europe, EVERSANA. Mike Ryan has worked across the life sciences and… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
You are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
You are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.